Putnam VT Global Health Care Fund is a registered fund series of Putnam Variable Trust (series S000003874). Net assets $141.3M as of 2026-03-31.
Showing 15 of 103 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| Eli Lilly & Co. | — | $15.2M | 1075.35% |
| Johnson & Johnson | — | $13.0M | 917.42% |
| AbbVie, Inc. | — | $8.5M | 601.83% |
| Novartis AG | — | $7.4M | 523.42% |
| Merck & Co., Inc. | — | $7.0M | 494.15% |
| UnitedHealth Group, Inc. | — | $7.0M | 492.92% |
| AstraZeneca plc | — | $6.9M | 491.72% |
| Thermo Fisher Scientific, Inc. | — | $6.4M | 450.83% |
| Intuitive Surgical, Inc. | — | $5.7M | 405.85% |
| Sanofi SA | — | $5.1M | 357.79% |
| Putnam Short Term Investment Fund | — | $4.2M | 294.47% |
| Boston Scientific Corp. | — | $3.9M | 277.42% |
| Gilead Sciences, Inc. | — | $3.8M | 272.23% |
| Roche Holding AG | — | $3.7M | 263.52% |
| McKesson Corp. | — | $3.5M | 248.65% |
| Report date | Net assets |
|---|---|
| 2026-03-31 | $141.3M |
| 2025-12-31 | $149.2M |
| 2025-09-30 | $138.2M |
| 2025-06-30 | $137.4M |
| 2025-03-31 | $150.2M |
| 2024-12-31 | $148.7M |
| 2024-09-30 | $172.1M |
| 2024-06-30 | $167.7M |